Impairment of the cholinergic anti-inflammatory pathway in older subjects with severe COVID-19

Med Hypotheses. 2020 Nov:144:110274. doi: 10.1016/j.mehy.2020.110274. Epub 2020 Sep 16.
No abstract available

Keywords: Alzheimer’s disease; COVID-19; Cholinergic anti-inflammatory pathway (CAP); Immunosenescence.

Publication types

  • Letter

MeSH terms

  • Acetylcholinesterase / metabolism
  • Aged
  • Aging*
  • Alzheimer Disease / complications
  • Alzheimer Disease / immunology*
  • Brain / immunology
  • Brain / metabolism
  • Butyrylcholinesterase / metabolism
  • COVID-19 / complications*
  • COVID-19 / immunology*
  • Cholinergic Agents / metabolism
  • Cytokines / blood
  • Cytokines / metabolism
  • Dementia / complications
  • Dementia / immunology*
  • Humans
  • Immunity, Innate
  • Inflammation / virology*
  • Neuroimmunomodulation
  • T-Lymphocytes / immunology

Substances

  • Cholinergic Agents
  • Cytokines
  • Acetylcholinesterase
  • Butyrylcholinesterase